MIMESIS Newsletter #4: A novel systems biology approach to develop preclinical assets

MIMESIS NEWSLETTER #4, December 2018

After two years, ENYO Pharma’s EU funded MIMESIS project was a real success and has delivered several promising new drug development starting points most significantly for RSV and ICD.

MIMESIS is a research and innovation project coordinated by ENYO Pharma and funded under the highly selective H2020 – SMEInstrument – Phase 2 call that aims at: “Dedicated support to biotechnology SMEs closing the gap from lab to market”.

Download newsletter (PDF)

Read next in 'Latest news'